Summit Therapeutics plc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

Latest Posts

About This Stock More About This Stock
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
Article By: ChinaBio® Today
Saturday, August 19, 2023 2:38 PM EDT
Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a $3.5 million milestone.
In this article: ONBI Also: MRK, SMMT, GDTC, ARQT
Read
Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug
Article By: ChinaBio® Today
Saturday, January 28, 2023 3:00 PM EDT
Shanghai’s HutchMed out-licensed global rights for a colorectal cancer therapy to Japan’s Takeda in a deal worth up to $1.13 billion, including $400 million upfront. In addition to the $1.13 billion, HutchMed will also pay royalties on net sales.
In this article: HCM, TAK Also: SMMT, LEGN, SBHMY, SHJBF, ASCLF
Read
Selloff Deepens As Covid-19 Casts Shadow Over Holidays
Article By: Schaeffers Research
Monday, December 20, 2021 12:38 PM EDT
This morning's selloff has deepened by midday, as investors assess how the rapidly spreading Covid-19 omicron variant could impact the holiday season.
In this article: QQQ, SPX, VIX, DJI, SMMT, SOPA, GRAB
Read
Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer, And More
Article By: Benzinga
Saturday, May 15, 2021 2:13 PM EDT
A couple of chief executive officers and an executive board chair were among the insiders buying shares this past week. As well, a master limited partnership, a real estate investment trust, and a conglomerate were also partaking in insider buying.
In this article: BH, CAR, ATVI, GOGO, AMH, UNVR, SMMT, PFSI, ET, SDC
Read
US Stock Market Weekly Update Nov. 9 - 13, 2020
Article By: Stavros Georgiadis
Sunday, November 15, 2020 12:00 PM EDT
After the stock market rally the previous week that was driven by the election outcome, this week the dominant theme was a risk-on mood due to positive vaccine news and developments related to the coronavirus pandemic.
In this article: INOD, SMMT, DCT, RBA, KZIA, VITL
Read

Latest Tweets for $SMMT

No tweets yet!

PARTNER HEADLINES